Latest News

Date Title Topic
01 Oct 2013 ESMO @ ECC 2013: Primary Endpoint Unmet in a Phase III Trial of First-Line Treatment with Palifosfamide plus Doxorubicin in Patients with Metastatic Soft Tissue Sarcoma Sarcomas
01 Oct 2013 ESMO Press Release: More Research Urged to Compare and Validate Genomic Tests in Oncology - ESMO Press Commentary Personalised medicine
01 Oct 2013 ECC 2013 Press Release: Variations in Death Rates after Surgery for Oesophageal and Gastric Cancers Prompt European Initiative to Improve Patient Outcomes Gastrointestinal cancers
30 Sep 2013 ECC Press Release: The State of Oncology 2013 – New Report Draws Attention to Urgent Need to Tackle Disparities in Cancer Care Worldwide Bioethics, legal and economic issues
30 Sep 2013 ESMO @ ECC 2013: Cediranib Shows Benefit in Women with Relapsed, Platinum-Sensitive Ovarian Cancer (ICON6) Gynaecologic malignancies
30 Sep 2013 ESMO @ ECC 2013: No Benefit Seen from Adding Zalutumumab to Radiotherapy in Patients with Squamous Cell Carcinoma of the Head and Neck Head and neck cancers
30 Sep 2013 ECC 2013 Press Release: Biological Therapy with Cediranib Improves Survival in Women with Recurrent Ovarian Cancer Gynaecologic malignancies - Anticancer agents & Biologic therapy
30 Sep 2013 ESMO @ ECC 2013: Targeted Treatment Options May Arise from Molecular Profiling of Patients with Cancers of Unknown Primary Site Carcinoma of unknown primary site
30 Sep 2013 ECC 2013 Press Release: New Research shows how Aspirin may act on Blood Platelets to Improve Survival in Colon Cancer Patients Cancer prevention - Gastrointestinal cancers
30 Sep 2013 ESMO Press Release: Only One in Five Female Oncologists Have a Leadership Position Bioethics, legal and economic issues
30 Sep 2013 ECC 2013 Press Release: First Estimate of Amount of Radiotherapy Dose Wasted in Compensating for Tumour Growth between Treatments Breast cancer
30 Sep 2013 ECC 2013 Press Release: Organised Screening for Prostate Cancer using the Prostate-Specific Antigen Test, Does more Harm than Good Cancer prevention - Genitourinary cancers
29 Sep 2013 ESMO Press Release: The landscape of medical oncology in Europe by 2020 - ESMO Commentary Bioethics, legal and economic issues
29 Sep 2013 ESMO Press Release: New approaches to testing cancer drugs needed - ESMO Commentary Personalised medicine
29 Sep 2013 ESMO @ ECC 2013: A Phase III Study of Tivantinib Plus Erlotinib Did Not Meet a Primary Endpoint in Patients with Locally-advanced or Metastatic, Non-squamous NSCLC Lung and other thoracic tumours - Anticancer agents & Biologic therapy